semaglutide vs tirzepatide review Today's TRIUMPH-4 results are a clear signal: the next generation of incretin medications will be more powerful than anything we've seen before. Retatrutide is showing nearly 30% body-weight reduction in clinical trials New Self Tirzepatide Reviews

We focus on what works

As of May 2025, Takeda reaffirmed its FY2024 revenue outlook and reported strong momentum, driven by new product launches and an expansion of its core operating profit margin

Wolverine Stack BPC-157 + TB-500 recovery stack

deAssis PMCastroLSSiqueiraAFDelgadoJde CHamiltonTRGoissisMDet al

SURMOUNT-1 results In this 72-week obesity trial, participants receiving tirzepatide achieved remarkable weight loss results: 5 mg dose: 85% achieved at least 5% weight reduction, with average weight loss of 15% 10 mg dose: 89% achieved at least 5% weight reduction, with average weight loss of 19% 15 mg dose: 91% achieved at least 5% weight reduction, with average weight loss of 21% These results were achieved with consistent weekly dosing

however, you should consult your healthcare provider for specific instructions